Histone deacetylase SIR2 in Toxoplasma gondii modulates functions of murine macrophages in vitro and protects mice against acute toxoplasmosis in vivo

被引:4
|
作者
Yu, ZhengQing [1 ]
Chen, SiYing [1 ]
Aleem, MuhammadTahir [1 ]
He, SuHui [1 ]
Yang, Yang [1 ]
Zhou, TianYuan [1 ]
Liu, JunLong [2 ]
Luo, JianXun [2 ]
Yan, RuoFeng [1 ]
Xu, LiXin [1 ]
Song, XiaoKai [1 ]
Li, XiangRui [1 ]
机构
[1] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Nanjing, Jiangsu, Peoples R China
[2] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou, Peoples R China
关键词
Toxoplasma gondii; Histone deacetylase; Silent information regulator 2 (SIR2); Murine macrophage; Protective immunity; NITRIC-OXIDE PRODUCTION; CD4(+) T-CELLS; IFN-GAMMA; TNF-ALPHA; GENE-EXPRESSION; DNA VACCINE; INFECTION; STRAINS; RESISTANCE; INHIBITORS;
D O I
10.1016/j.micpath.2021.104835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Silent information regulator 2 (SIR2) in histone deacetylase (HDAC) is particularly conserved and widely expressed in all eukaryotic cells. HDAC is a crucial post-translational modification protein regulating gene expression. In the present study, a Toxoplasma gondii (T. gondii) silent information regulator 2 (TgSIR2) gene in HDAC was cloned and the modulation effects of recombinant TgSIR2 (rTgSIR2) on murine Ana-1 macrophages were characterized in vitro. The results indicated that rTgSIR2 had a good capacity to eliminate T. gondii by promoting proliferation, apoptosis, and phagocytosis, and modulating the secretion of nitric oxide (NO), proinflammatory cytokines, and anti-inflammatory cytokines. In in vivo experiments, animals were immunized with recombinant TgSIR2, followed by a lethal dose of T. gondii RH strain challenge 14 days after the second immunization. As compared to the blank and control group, the animals immunized with rTgSIR2 could generate specific humoral responses, as demonstrated by the significantly high titers of total IgG and subclasses IgG1 and IgG2a. Significant increases of IFN-gamma, IL-4, and IL-10 were seen, while no significant changes were detected in IL17. The percentage of CD4+ and CD8+ T lymphocytes in animals immunized with rTgSIR2 significantly increased. A significantly long survival time was also observed in animals vaccinated with rTgSIR2 14 days after the last immunization. All these results clearly indicate that rTgSIR2 played an essential role in modulating host macrophages and offered the potential to develop a therapeutic strategy against T. gondii.
引用
收藏
页数:13
相关论文
共 9 条
  • [1] Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo
    Yu, Zhengqing
    Lu, Yujia
    Liu, Zhaoyi
    Aleem, Muhammad Tahir
    Liu, Junlong
    Luo, Jianxun
    Yan, Ruofeng
    Xu, Lixin
    Song, Xiaokai
    Li, Xiangrui
    VACCINES, 2021, 9 (04)
  • [2] Nano DNA Vaccine Encoding Toxoplasma gondii Histone Deacetylase SIR2 Enhanced Protective Immunity in Mice
    Yu, Zhengqing
    Lu, Yujia
    Cao, Wandi
    Aleem, Muhammad Tahir
    Liu, Junlong
    Luo, Jianxun
    Yan, Ruofeng
    Xu, Lixin
    Song, Xiaokai
    Li, Xiangrui
    PHARMACEUTICS, 2021, 13 (10)
  • [3] Auranofin Is Highly Efficacious against Toxoplasma gondii In Vitro and in an In Vivo Experimental Model of Acute Toxoplasmosis
    Andrade, Rosa M.
    Chaparro, Juan D.
    Capparelli, Edmund
    Reed, Sharon L.
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (07):
  • [4] Toxoplasma gondii Histone 4 Affects Some Functions of Murine Ana-1 Macrophages In Vitro
    Liu, Xinchao
    Li, Xiaoyu
    Wang, Qiangqiang
    Sun, Xiaoni
    Lu, Mingmin
    Ehsan, Muhammad
    Xu, Lixin
    Yan, RuoFeng
    Song, XiaoKai
    Li, XiangRui
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2018, 65 (06) : 860 - 869
  • [5] In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis
    Montazeri, Mahbobeh
    Emami, Saeed
    Asgarian-Omran, Hossein
    Azizi, Soheil
    Sharif, Mehdi
    Sarvi, Shahabeddin
    Rezaei, Fatemeh
    Sadeghi, Mitra
    Gohardehi, Shaban
    Daryani, Ahmad
    EXPERIMENTAL PARASITOLOGY, 2019, 200 : 7 - 12
  • [6] Live Attenuated Pru:Δcdpk2 Strain of Toxoplasma gondii Protects Against Acute, Chronic, and Congenital Toxoplasmosis
    Wang, Jin-Lei
    Li, Ting-Ting
    Elsheikha, Hany M.
    Chen, Kai
    Cong, Wei
    Yang, Wen-Bin
    Bai, Meng-Jie
    Huang, Si-Yang
    Zhu, Xing-Quan
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (05): : 768 - 777
  • [7] DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice
    Chen, Jia
    Huang, Si-Yang
    Zhou, Dong-Hui
    Li, Zhong-Yuan
    Petersen, Eskild
    Song, Hui-Qun
    Zhu, Xing-Quan
    VACCINE, 2013, 31 (52) : 6225 - 6231
  • [8] Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice
    Zhang, Dongchao
    Jiang, Ning
    Chen, Qijun
    VACCINE, 2019, 37 (08) : 1118 - 1125
  • [9] Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice
    Cao, Aiping
    Liu, Yuan
    Wang, Jingjing
    Li, Xun
    Wang, Shuai
    Zhao, Qunli
    Cong, Hua
    He, Shenyi
    Zhou, Huaiyu
    VACCINE, 2015, 33 (48) : 6757 - 6762